Quanta Pharma SLU-PP-332 20mg

is a novel ERRα/γ agonist researched for enhancing endurance, metabolic function, and exercise capacity without physical training. This Quanta Pharma formulation delivers 60 tablets at 20mg each. Janoshik lab verified at 21.87mg per tablet, confirming accurate dosing. Often referred to as “exercise in a pill” for its performance-enhancing research applications.

ℹ️

Packaging Update – February 2026

We’ve switched to a smaller tub and smaller tablets. The product itself is exactly the same, we’ve just updated our pressing procedures.

Janoshik Laboratory Verified

Independent third-party testing confirms purity and concentration

Actual Content

Label Claim

Accuracy

Verification Key:

FK4PKY9KD13E  |

Tested:

October 2025  |

View Full Report

Quanta Pharma SLU-PP-332 20mg

is a cutting-edge ERRα/γ (estrogen-related receptor) agonist that has gained significant attention in performance research. Often dubbed “exercise in a pill,” this

Quanta Pharma

compound is being studied for its remarkable ability to enhance endurance and metabolic function without the need for physical training. Janoshik laboratory testing confirms accurate dosing at 21.87mg per tablet. Dispatched from UK stock for fast delivery.

Quanta Pharma SLU-PP-332 Specifications

Tablets

Dose Per Tablet

Half-Life

4-6 Hours

Administration

Oral

Official Quanta Pharma Verified Reseller

Pharmaceutical-grade compounds • UK stock • Fast dispatch

Quanta Pharma SLU-PP-332 Research Benefits

Enhanced Endurance

Metabolic Activation

Fat Oxidation

Muscle Fibre Adaptation

No Training Required

How Quanta Pharma SLU-PP-332 Works

Quanta Pharma SLU-PP-332

works by activating estrogen-related receptors alpha and gamma (ERRα/γ), which are key regulators of energy metabolism, mitochondrial biogenesis, and oxidative phosphorylation. These receptors control genes involved in fatty acid oxidation, glucose metabolism, and the formation of new mitochondria.

Research published in leading scientific journals has demonstrated that

Quanta Pharma SLU-PP-332

can mimic many of the beneficial adaptations normally associated with endurance exercise training. Studies in animal models showed dramatic improvements in running endurance, increased oxidative muscle fibres, and enhanced metabolic markers without any physical training stimulus.

Quanta Pharma SLU-PP-332 vs GW501516 (Cardarine)

Both

Quanta Pharma SLU-PP-332

and GW501516 are researched for endurance enhancement, but they work through different mechanisms. GW501516 is a PPARδ agonist, whilst

SLU-PP-332

targets ERR receptors.

Quanta Pharma SLU-PP-332

is a newer compound with a potentially improved safety profile based on its mechanism of action. Many researchers are now favouring

Quanta Pharma

SLU-PP-332 as an alternative approach to metabolic and endurance research.

Why Choose Quanta Pharma SLU-PP-332?

Quanta Pharma

is renowned for producing pharmaceutical-grade compounds with exceptional quality and accurate dosing. Every batch of

Quanta Pharma SLU-PP-332

undergoes rigorous quality control and Janoshik laboratory verification. With confirmed content of 21.87mg per tablet (slightly overdosed), you can trust that each bottle delivers precisely what’s promised.

⚠️ FOR RESEARCH USE ONLY

NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE

Legal Notice:

This product is intended for research purposes only. The purchaser accepts that acquiring and using this material is governed by all relevant UK regulations. Not for use in dietary supplements, food products, or for any unlawful purpose.